Dopaminergic neurons control aspects of mood, cognition and movement, and are involved in the pathogenesis of a variety of brain disorders including drug addiction. A central regulator of dopaminergic neurotransmission is the dopamine (DA) transporter (DAT) that is expressed exclusively in dopaminergic neurons and is responsible for clearance of extracellular DA. Psychostimulants such as amphetamines and cocaine elicit dramatic behavioral phenotypes primarily by targeting DAT directly and increasing extracellular DA concentration. DA neurons are functionally heterogeneous and morphologically complex, with spatially separated somatodendritic and axonal domains, and dense axonal arborizations. Proper DAT distribution in the DA neuron is critical for the function of the dopaminergic system in its normal and diseased states. The principal goal of this proposal is to elucidate mechanisms by which the DAT-mediated substrate re- uptake is regulated in DA neurons by endocytosis, long-distance intraneuronal trafficking and membrane diffusion. We have developed and characterized a knock-in mouse that expresses an extracellular epitope (HA)-tagged DAT (HA-DAT). In this mice we used a combination of quantitative electron microscopy of intact brain and acute sagittal brain slices, a novel physiological ex vivo model of the intact DA neuron, to demonstrate distinct patterns of DAT trafficking in different regions of DA neurons. Using mechanistic analysis in cultured cells, we have identified molecular determinants in the DAT that are involved in its targeting to filopodia and its mobility in the plasma membrane, and novel sequence motifs that are important for constitutive and signal-induced DAT endocytosis. We propose that since intraneuronal distribution of DAT is regulated by the balance of vesicular traffic, cell surface retention and membrane mobility of DAT, these processes must be controlled differently by intracellular signaling in somatodendritic and axonal domains of neurons and in different areas of the striatum and midbrain. To test these hypotheses, we will: 1) Define kinetics and mechanisms of long-distance DAT trafficking between spatially separated axonal and somatodendritic domains of DA neurons; 2) Define routes, kinetics, and mechanisms of constitutive and signal- induced endocytosis of DAT in DA neurons; 3) Test whether brain region- and signal-specific DAT trafficking affects DAT substrate transport kinetics. Defining mechanisms of DAT regulation by trafficking in intact DA neurons will significantly advance our understanding of the cell biology and physiology of the DA system, and may suggest potential therapeutic options for treatment of DA pathologies such as drug addiction.

Public Health Relevance

The neurotransmitter dopamine is essential for central nervous system control of locomotor activity, cognition and reward mechanisms. As such, dopamine is involved in several neurodegenerative and neuropsychiatric disorders, such as Parkinson?s disease, schizophrenia, Tourette?s syndrome, ADHD and drug addiction. Dopamine transporter (DAT) is a principal target of cocaine, methylphenidate and amphetamines. Revealing the components and processes that regulate DAT in intact brain as proposed in this application may lead to new strategies in the therapeutic intervention with brain pathologies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA014204-15A1
Application #
9309642
Study Section
Neurotransporters, Receptors, and Calcium Signaling Study Section (NTRC)
Program Officer
Tsai, Shang-Yi Anne
Project Start
2001-09-15
Project End
2022-06-30
Budget Start
2017-09-15
Budget End
2018-06-30
Support Year
15
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Kaya, Cihan; Cheng, Mary H; Block, Ethan R et al. (2018) Heterogeneities in Axonal Structure and Transporter Distribution Lower Dopamine Reuptake Efficiency. eNeuro 5:
Sorkina, Tatiana; Ma, Shiqi; Larsen, Mads Breum et al. (2018) Small molecule induced oligomerization, clustering and clathrin-independent endocytosis of the dopamine transporter. Elife 7:
Ma, Shiqi; Cheng, Mary H; Guthrie, Daryl A et al. (2017) Targeting of dopamine transporter to filopodia requires an outward-facing conformation of the transporter. Sci Rep 7:5399
Martínez-Mármol, Ramón; Styrczewska, Katarzyna; Pérez-Verdaguer, Mireia et al. (2017) Ubiquitination mediates Kv1.3 endocytosis as a mechanism for protein kinase C-dependent modulation. Sci Rep 7:42395
Martínez-Mármol, Ramón; Comes, Núria; Styrczewska, Katarzyna et al. (2016) Unconventional EGF-induced ERK1/2-mediated Kv1.3 endocytosis. Cell Mol Life Sci 73:1515-28
Tucker, Kristal R; Block, Ethan R; Levitan, Edwin S (2015) Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles. Proc Natl Acad Sci U S A 112:E4485-94
O'Donnell, Allyson F; McCartney, Rhonda R; Chandrashekarappa, Dakshayini G et al. (2015) 2-Deoxyglucose impairs Saccharomyces cerevisiae growth by stimulating Snf1-regulated and ?-arrestin-mediated trafficking of hexose transporters 1 and 3. Mol Cell Biol 35:939-55
Cheng, Mary Hongying; Block, Ethan; Hu, Feizhuo et al. (2015) Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding. Front Neurol 6:134
Prosser, Derek C; Pannunzio, Anthony E; Brodsky, Jeffrey L et al. (2015) ?-Arrestins participate in cargo selection for both clathrin-independent and clathrin-mediated endocytosis. J Cell Sci 128:4220-34
Caltagarone, John; Ma, Shiqi; Sorkin, Alexander (2015) Dopamine transporter is enriched in filopodia and induces filopodia formation. Mol Cell Neurosci 68:120-30

Showing the most recent 10 out of 40 publications